Patents Assigned to Suzhou Baijibugong Pharmaceutical Technology Co., Ltd.
  • Bruton's tyrosine kinase inhibitors
    Patent number: 11974999
    Abstract: Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):
    Type: Grant
    Filed: January 1, 2021
    Date of Patent: May 7, 2024
    Assignees: Suzhou Baijibugong Pharmaceutical Technology Co., Ltd.
    Inventors: Xibin Liao, Jia Li, Zhijian Lu, Yubo Zhou, Anhui Gao
  • Bruton's tyrosine kinase inhibitors
    Patent number: 11554118
    Abstract: Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: January 17, 2023
    Assignees: SUZHOU BAIJIBUGONG PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Xibin Liao, Jia Li, Zhijian Lu, Yubo Zhou, Anhui Gao
  • Bruton's tyrosine kinase inhibitors
    Patent number: 10933063
    Abstract: Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: March 2, 2021
    Assignees: Suzhou Baijibugong Pharmaceutical Technology Co., Ltd.
    Inventors: Xibin Liao, Jia Li, Zhijian Lu, Yubo Zhou, Anhui Gao